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Background: Since an objective description is essential to determine infant’s postnatal condition and efficacy of
interventions, two scores were suggested in the past but weren’t tested yet: The Specified-Apgar uses the 5 items
of the conventional Apgar score; however describes the condition regardless of gestational age (GA) or resuscitative
interventions. The Expanded-Apgar measures interventions needed to achieve this condition. We hypothesized that
the combination of both (Combined-Apgar) describes postnatal condition of preterm infants better than either of
the scores alone.
Methods: Scores were assessed in preterm infants below 32 completed weeks of gestation. Data were prospectively
collected in 20 NICU in 12 countries. Prediction of poor outcome (death, severe/moderate BPD, IVH, CPL and ROP) was
used as a surrogate parameter to compare the scores. To compare predictive value the AUC for the ROC was calculated.
Results: Of 2150 eligible newborns, data on 1855 infants with a mean GA of 286/7 ± 23/7 weeks were analyzed. At
1 minute, the Combined-Apgar was significantly better in predicting poor outcome than the Specified- or Expanded-Apgar
alone. Of infants with a very low score at 5 or 10 minutes 81% or 100% had a poor outcome, respectively. In these
infants the relative risk (RR) for perinatal mortality was 24.93 (13.16-47.20) and 31.34 (15.91-61.71), respectively.
Conclusion: The Combined-Apgar allows a more appropriate description of infant’s condition under conditions of
modern neonatal care. It should be used as a tool for better comparison of group of infants and postnatal interventions.
Trial registration: clinicaltrials.gov Protocol Registration System (NCT00623038). Registered 14 February 2008.
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management, Preterm resuscitationBackground
An objective assessment of infant’s postnatal condition
in the delivery room is essential for clinical care and sci-
entific purposes. To describe the postnatal condition of
groups of infants or to compare effects of interventions
in a research setting a numerical score, which represents
the sum of several objective findings is required.
To describe the condition of a newborn, Virginia
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unless otherwise stated.condition by converting clinical observations into quan-
tifiable scientific data [1]. However, there is no general
agreement on how to score infants with a low gesta-
tional age or those receiving interventions [2-4]. To
overcome that problem, we suggested to specify the
items of the conventional Apgar and to score infant’s
condition regardless of gestational age and interventions
(Specified-Apgar) [5]. According to the rules of the
Specified-Apgar, the full score with a maximum total of
10 points can either be allocated to the healthy term or
preterm infant without any problems in postnatal adap-
tation, but also to an infant receiving resuscitative or
supportive interventions with an adequate response tol. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Combined-Apgar consisting of the Expanded-
Apgar and Specified-Apgar
Minute
1 5 10
C CPAP#
O Oxygen Supplementation
M-B Mask and Bag Ventilation##
I Intubation and Ventilation
N Neonatal Chest Compression
E Exogenous Surfactant Administration
D Drugs
0 = intervention was performed
1 = no intervention
# Score 0, if ‘Mask and Bag Ventilation’ or ‘Intubation and Ventilation is
scored 0.
## Score 0, if ‘Intubation and Ventilation’ is scored 0.
Sum of the Expanded-Apgar:
Skin Color* 2 = completely pink
A 1 = centrally pink with acrocyanosis
0 = centrally blue or pale
Heart Frequency* 2= >100/min
P 1 = 100-1/min
0 = no heart beat
Reflex 2 = appropriate for gestational age
G 1 = reduced for gestational age
0 = no reflex responses
Muscle Tone 2 = appropriate for gestational age
A 1 = reduced for gestational age
0 = completely flaccid
Chest Movement* 2 = regular chest movement
R 1 = small or irregular chest movement
0 = no chest movement
*Independent of the requirements needed to achieve this condition
Sum of the Specified-Apgar:
Total (Expanded- + Specified-Apgar):
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tion, pink skin colour due to supplemental oxygen, etc.).
To better differentiate between both conditions, the
American Academy of Pediatrics (AAP) and American
College of Obstetricians and Gynecologists (ACOG) sug-
gested to also score and document the interventions that
are required to achieve the condition (Expanded-Apgar)
[6]. Consequently, an infant without any interventions
would have a higher Expanded-Apgar than the one who
requires interventions. It can be assumed that an in-
fant’s condition is better described using both scores
(Combined-Apgar) simultaneously than one score alone.
Up until now, both scores are not used in clinical
practise mainly because of not being validated yet.
The multicenter, international TEST-Apgar study (“Trial
to Evaluate a Specified Type of Apgar”) aimed to answer
the question, whether the Combined-Apgar describes in-
fant’s postnatal condition better than either the Specified-
Apgar or Expanded-Apgar alone. Since no “gold standard”
was available, we decided to use prediction of mortality
and morbidity as a proxy for testing. That outcome criter-
ion was only used as a surrogate parameter for the pur-
pose of testing the scores. It was not the aim to develop a
new tool which predicts mortality or morbidity, but to test
that the Combined-Apgar provides a good numerical de-
scription of infant’s postnatal condition.
Therefore, the primary hypothesis of the TEST-Apgar
study was as follows: the Combined-Apgar is a better pre-
dictor of poor outcome in preterm infants (defined as either
death or any major morbidity during the first hospital stay)
than either the Specified-Apgar or Expanded-Apgar alone.
Methods
In an observational study data were collected prospect-
ively in 20 academic neonatal intensive care units (NICU)
in 12 countries from March 2008 to June 2009.
Inclusion and exclusion criteria
Infants were eligible if they were born at any of the study
sites prior to 32 completed weeks of gestation. The exclu-
sion criteria were: 1.) lack of informed consent, 2.) outborn,
3.) any major congenital malformation, or 4.) death in the
delivery room.
Data
After birth, the following data were collected by the at-
tending neonatologist: gestational age, birth weight,
mode of delivery and a description of the infant at 1, 5
and 10 minutes of life according to the definition of the
Combined-Apgar, which consists of the Expanded-Apgar
and Specified-Apgar as shown in Table 1:
1. Specified-Apgar [5]: Muscle tone and reflex response
were evaluated in relation to GA as being appropriate(2 points), reduced (1 point) or absent (0 points). Chest
movement was evaluated regardless of the respiratory
support given and was scored 2 if chest movements
were appropriate, with 1 point if chest movements
were reduced, irregular or signs of respiratory distress
were present, and scored 0 if no chest movement was
present. Skin color and heart frequency were evaluated
as detailed in Table 1, regardless of the intervention
needed to achieve this condition.
2. Expanded-Apgar [6]: Presence or absence of the
following interventions was evaluated: continuous
positive airway pressure (CPAP), oxygen
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intubation and ventilation, chest compression,
administration of surfactant, epinephrine (drugs). If
an intervention was performed it was scored 0, if
absent it was scored 1. The best possible score was 7
(no intervention) and the worst 0 (all interventions
performed). Intubated and ventilated infants were
scored 0 for CPAP as well as for bag and mask
ventilation; infants on bag and mask ventilation were
scored 0 for CPAP as well.
3. Combined-Apgar: In clinical routine, the Combined-
Apgar will consist of two numbers, such as 7–10 for
the Expanded- and Specified-Apgar, respectively
(Table 1). For the purpose of the present study, the
Combined-Apgar was calculated as the sum of the
Specified- and the Expanded-Apgar.
At discharge the following outcome measures were re-
corded: mode of discharge (death, transfer to another
hospital, or home), length of stay, corrected GA, weight,
and the presence of either of the four major morbidities:
moderate/severe bronchopulmonary dysplasia (BPD) [7],
intraventricular haemorrhage grade 1–4 (IVH), cystic
periventricular leukomalacia (CPL), and retinopathy of
prematurity (ROP).
Data management and statistical analyses
Participating doctors were instructed regarding defini-
tions and study forms prior to the start of the study at
the individual center. Data collected at participating sites
were transmitted to the principal investigator and ana-
lyzed for the primary outcome criterion consisting of
death or either one of the major morbidities (BPD, IVH,
CPL, ROP). To test the hypothesis, the predictive values
of the scores were compared by calculating the areas
under the curve (AUC) and their co-variances of the
receiver-operating-characteristics (ROC), based on an al-
gorithm given by DeLong and co-workers [8]. The com-
parisons of AUCs base on WALD tests. The significance
of differences between estimated risks was tested by
Chi-square tests; p-values are unadjusted for multiple
testing. For sample size calculation a difference in AUC
means of 0.01 and a SD in matched pairs of 0.1 were as-
sumed. To detect a significant difference at a level of
p = 0.01 with a power of 0.9 data of 1490 infants were
required. Assuming a dropout rate of 30%, it was
planned to recruit 2000 patients. For secondary data
analysis, the AUC was calculated for each individual
component of poor outcome. Data on mortality were an-
alyzed for “death at any point” and “perinatal mortality”.
Furthermore, for each outcome criteria the relative risk
(RR) and 95% confidence interval (95%-CI) were cal-
culated. To do so, scores were categorized as follows:
Specified-Apgar: poor (0–3 points), fair (4–6 points) orgood (7–10 points) [9], Expanded-Apgar: low (0–2
points), moderate (3–4 points), high (5–6 points) or no
intervention (7 points); Combined-Apgar: very low (0–5
points), low (6–9 points), moderate (10–13 points) or
high (14–17 points). The respectively highest category of
each score was used as reference value. All analyses were
performed by using SAS (SAS Institute Inc., Cary, NC,
version 9.2).
Ethics committee approval
Approval was given by the Ethics Committee of the
Medical Faculty Carl Gustav Carus, Dresden, Germany
(EK 104052008) and in all participating centers. Written
informed consent was obtained from the infant’s parents
before taking part in the study. The study was registered
on ClinicalTrials.gov Protocol Registration System (NCT
00623038).
Results
Patient characteristics
In total, 2150 infants were eligible for the study. Two
hundred ninety five had to be excluded from analysis for
the following predetermined reasons: Missing parental
consent (n = 28), outborn (n = 24), congenital anomalies
(n = 16), palliative care (n = 16), transferral within first
week of life (n = 3), no paediatrician present (n = 2),
incomplete data (n = 143), other reasons (n = 63). Perinatal
data of excluded patients (mean GA of 283/7 ± 23/7 weeks,
birth weight 1119 ± 388 g) were statistically not different
from those of analyzed patients.
Data of 1855 patients were analyzed, representing in
median 89 (Range 21–228) patients per center with a
mean GA of 286/7 ± 23/7 weeks and birth weight of
1172 ± 409 g.
The overall mortality rate was 10.6%. For the individ-
ual centers, the median mortality rate was 8.8% [Inter-
quartile Range (IQR) 4.8-12.3%]. Infants were discharged
home at a median postconceptional age of 362/7 weeks
(length of stay in survivors 53 [IQR 35–75] days).
Gestational age – effect on clinical condition and need for
medical interventions
The postnatal condition during the first minute of life
showed a linear correlation with gestational age; with
the Specified-Apgar scoring higher at higher gestational
age (Figure 1A). In contrast, there was no linear correl-
ation between gestational age and medical interventions
(Expanded-Apgar) at one minute; medical support was
almost similar for infants below 28 weeks of gestation
(Figure 1C).
At 10 minutes, clinical condition of all infants was
similar regardless of gestational age (Figure 1B). How-
ever, medical support to achieve this condition increased
with decreasing gestational age (Figure 1D).
Figure 1 Distribution-pattern of the Specified-Apgar (A, B) and Expanded-Apgar (C, D) at 1 and 10 minutes. In the boxplot, the central
box represents the values from the lower to upper quartile (25 to 75 percentile). The middle line represents the median. The vertical line extends
from the minimum to the maximum value. Outlier values are displayed as black dots, extreme values are displayed as an asterix.
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To test the primary hypothesis, the AUC of ROC-curves
for prediction of poor outcome were calculated and
compared (Table 2). At 1 minute, the Combined-Apgar
predicts poor outcome significantly better than theTable 2 Area under the curve (AUC) of the ROC-Curve for the
Specified-Apgar p-
AUC (95%-CI)
Poor Outcome 1 Minute 0.63 (0.59 to 0.68) <.0
5 Minutes 0.63 (0.59 to 0.67) <.0
10 Minutes 0.61 (0.56 to 0.65) <.0
Morbidity in survivors 1 Minute 0.58 (0.54 to 0.61) <.0
5 Minutes 0.57 (0.53 to 0.60) <.0
10 Minutes 0.55 (0.51 to 0.59) <.0
Death 1 Minute 0.68 (0.64 to 0.71) <.0
5 Minutes 0.68 (0.65 to 0.72) <.0
10 Minutes 0.67 (0.63 to 0.70) <.0
Perinatal mortality 1 Minute 0.73 (0.69 to 0.76) <.0
5 Minutes 0.72 (0.69 to 0.76) <.0
10 Minutes 0.71 (0.67 to 0.74) <.0
Shown are the values for the Area under the curve (AUC) and 95%-CI of the ROC-curve
mortality by the Specified-Apgar, Expanded-Apgar and Combined-Apgar.
p-values are calculated vs. Combined-Apgar.Specified- or Expanded-Apgar alone. At 5 and 10 minutes,
the Combined-Apgar predicts poor outcome better than
the Specified-Apgar. However, there were no significant
differences in predicting poor outcome between Com-
bined- and Expanded-Apgar at 5 and 10 minutes.Specified-Apgar, Expanded-Apgar and Combined-Apgar
value Expanded-Apgar p-value Combined-Apgar
AUC (95%-CI) AUC (95%-CI)
01 0.64 (0.60 to 0.68) 0.007 0.66 (0.62 to 0.70)
01 0.70 (0.65 to 0.74) 1.00 0.69 (0.65 to 0.74)
01 0.70 (0.65 to 0.75) 1.00 0.70 (0.65 to 0.75)
01 0.58 (0.55 to 0.62) 0.61 0.59 (0.55 to 0.63)
01 0.63 (0.59 to 0.67) 0.002 0.62 (0.58 to 0.66)
01 0.64 (0.60 to 0.68) 0.008 0.63 (0.59 to 0.67)
01 0.67 (0.64 to 0.71) <.001 0.70 (0.67 to 0.74)
01 0.70 (0.66 to 0.74) <.001 0.73 (0.69 to 0.77)
01 0.68 (0.64 to 0.72) <.001 0.71 (0.67 to 0.75)
01 0.71 (0.68 to 0.75) <.001 0.76 (0.72 to 0.80)
01 0.74 (0.70 to 0.77) <.001 0.78 (0.74 to 0.82)
01 0.73 (0.70 to 0.77) <.001 0.77 (0.73 to 0.81)
for the prediction of poor outcome, morbidity in survivors, death and perinatal
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that overall morbidity in survivors was better predicted
by the number of interventions (Expanded-Apgar) at 5
and 10 minutes than by the actual condition (Specified-
Apgar) of the infant at that time (see Additional file 1:
Table A and Additional file 2: Table E). In contrast, death
(especially perinatal mortality) was better predicted by the
postnatal condition (Specified-Apgar) (see Additional file 2:
Table F). The Combined-Apgar was significantly better to
predict perinatal mortality than the Specified- or Expanded-
Apgar alone (see Additional file 3: Table J; Additional file 2:
Table F and Additional file 1: Table B).
Relative risk for morbidity or mortality for each score
Detailed data on the relative risk for morbidity and
mortality can be found as additional files (for the
Expanded-Apgar see Additional file 1: Table A-D; for the
Specified-Apgar see Additional file 2: Tables E-H; and for
the Combined-Apgar see Additional file 3: Tables I-L).
Infants with a persistently poor Specified-Apgar (<4)
up to minute 5 or minute 10 had a poor outcome in
75% or 93% (RR 1.67 [95%-CI 1.41 to 1.98] or 2.08 [1.80
to 2.40]), respectively. If the five outcome parameters
were analyzed separately, the Specified-Apgar cannot be
used to predict the morbidity risk. Best prediction was
found for mortality: the risk of death was significantly
increased with a poor and a fair Specified-Apgar (see
Additional file 2: Table F).
In 30% or 24% the Expanded-Apgar remained below 5
for up to 5 or 10 minutes, respectively. Less than 1% had
an Expanded-Apgar below 3 for up to 5 or 10 minutes.
The risk of poor outcome was below 30% in infants
without any intervention; however, it increased to aboveFigure 2 Combined-Apgar: Relative risk for perinatal mortality.50% with a moderate (score 3–4) and above 60% with a
low (score 0–2) Expanded-Apgar (see Additional file 1:
Table A). For the Combined-Apgar, the relative risk of
poor outcome increased with a decreasing score (see
Additional file 3: Table I). As shown in Figure 2, a very
low Combined-Apgar was associated with an about 30-
fold increased risk for perinatal mortality.
Discussion
A numerical score that represents the sum of objective
findings is a prerequisite to describe the postnatal condi-
tion or to compare effects of interventions in the deliv-
ery room for groups of infants. Since the infant’s
condition is affected by medical interventions, it seems
mandatory to describe not only the clinical status but
also the interventions needed to achieve this condition.
During the last centuries, various attempts have been
made to describe the infant’s condition after birth
[10-12]. Virginia Apgar developed a scoring system that
now bears her name and is widely used [1]. Since im-
provements in neonatal care demanded a recalibration
of the Apgar score [13], the Specified-Apgar was intro-
duced. Using the same items as the original score, it al-
lows detailed descriptions for the infant’s condition
regardless of GA or interventions [5]. To account for
medical interventions required to achieve this condition
the AAP and ACOG suggested an expanded reporting
form for concurrent resuscitative interventions (Expanded-
Apgar) [6]. Both scores together give an objective measure
of the postnatal condition; however this Combined-Apgar
has not been used in clinical studies yet. The multicenter
international TEST-Apgar study tested both scores for the
first time in a clinical setting. The data show that theRelative risk for perinatal mortality 
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tered interventions (Combined-Apgar) is better (to predict
death) than the description of condition or interventions
alone.
The description of the postnatal condition is incom-
plete without considering administered interventions.
The Expanded-Apgar adds seven items as a measure for
medical interventions needed to achieve the infant’s con-
dition [6]. This extension seems long needed, because
care of the newborn has changed significantly and an in-
fant’s condition often depends on medical interventions
used to support postnatal transition. In the present
study, the majority of infants showed a good clinical
condition at 10 minutes of life, however, the number of
interventions needed to achieve that condition increased
with decreasing gestational age.
The seven items of the Expanded-Apgar represent
medical interventions that are clearly defined. To our
knowledge, this is the first prospective clinical study to
show a direct relationship between the number of in-
terventions administered postnatally and subsequent
survival. The more interventions were given the more
likely the infant died within the first postnatal week.
All infants with a Combined-Apgar below 6 for at least
10 minutes had a bad outcome. However, at this mo-
ment it remains unclear whether all interventions were
clinically indicated or rather done as a result of current
practice in individual institutions. More detailed ana-
lyses will have to analyze if there are differences in the
predictive power of individual items of the Combined-
Apgar.
Clinical implications
In the past, the 1-minute Apgar score was used to guide
further treatment and the 5-minute score was a useful
index of the effect(iveness) of resuscitation efforts [14].
However, it remained unclear how infants were scored
during resuscitation. It was suggested to interrupt resus-
citation for evaluation purposes [3,15] but this approach
seems not practical. The Specified-Apgar describes the
condition without interrupting intervention and the
Expanded-Apgar adds the required information con-
cerning the interventions. Thus, the Combined-Apgar
evaluates both, infant’s condition and resuscitative ef-
forts and can be used to guide postnatal interventions.
A Combined-Apgar of 7–10 represents an infant with-
out any clinical interventions (Expanded-Apgar of 7)
and good clinical signs (Specified-Apgar of 10). In con-
trast a Combined-Apgar of 0–10 represents an infant
with full resuscitative interventions (Expanded-Apgar 0)
and a good clinical response (Specified-Apgar of 10). Fi-
nally, a Combined-Apgar of 0–0 represents an infant
with full resuscitative interventions but no clinical
response.Limitations of the study
It has been previously shown that not all items of the
conventional Apgar score are of equal importance [9,16].
However, Virginia Apgar did not differentially weigh or
remove individual items since it was her intention to
have a score that can be “determined easily and without
interfering with the care of the infant” [1]. The Combined-
Apgar never intended to replace but rather to specify the
score that has been used worldwide for almost 60 years.
Therefore, items were neither changed nor omitted. Fur-
thermore, definition of skin color was not changed despite
its poor correlation with oxygen saturation [17].
Questions that were not answered by the present study
Since there is no other objective measure to describe
postnatal condition, poor outcome was used as a surro-
gate parameter to test the value of the scores in preterm
infants. It has already been noted by Virginia Apgar that
her score cannot be used to predict survival in an indi-
vidual infant, but only for a group of infants [18,19]. For
a better prediction of outcome in individual infants
other more reliable scores should be used [19-21]. But it
remains unclear, whether this higher predictive value in
individuals is of relevance in clinical routine.
Whereas virtually every newborn is evaluated by the
Apgar score today, recent studies suggest problems con-
cerning its reproducibility in individual infants [2-4]. A
study, comparing conventional Apgar scores assigned by
observers of resuscitation videos to those given by the
staff attending the delivery, revealed a poor inter-
observer reliability [4]. Similarly, a poor reliability was
found when Apgar scores were assessed for written case
descriptions [3]. In clinics where case descriptions were
scored low, preterm infants received lower Apgar scores
as well [2]. It was speculated, that this variability “could
also be due to variations in the application of the scoring
system” [22]. To overcome its poor reproducibility, the
Specified-Apgar was introduced, which gives more de-
tailed descriptions of the infant’s condition regardless of
GA or interventions needed to achieve this condition
[5]. Strict definitions – as given by the Specified-Apgar –
are needed to minimise variability in the description of
infant’s condition. However, subsequent studies have to
test, whether reproducibility is actually improved by
using the Specified-Apgar.
Another important practical aspect of the Combined-
Apgar is its applicability for every newborn. The present
study has only tested the predictive power in very pre-
term infants, but the Apgar score is also of importance
in resuscitated infants (e.g. it is used as an inclusion cri-
terion for hypothermia) [23]. Considering the large vari-
ation in the conventional Apgar score for an individual
infant depending on the care givers opinion [2-4], it
could be assumed that the Combined-Apgar will be a
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the Combined-Apgar for subsequent neurological im-
pairment has to be tested in asphyxiated infants.
Conclusions
In summary, the present study tested a numerical score
(Combined-Apgar) that sums up objective findings upon
the condition of the infant in the delivery room and the
interventions needed to achieve this condition in a large
population of preterm infants. The Combined-Apgar is a
good tool to describe the postnatal condition in the
delivery room as shown by its ability to predict perinatal
mortality for groups of infants. It should be used in
subsequent studies that require a detailed description of
infant’s postnatal situation.
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